Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Laminins and Congenital Muscular Dystrophy - From a Mouse Model to Gene Therapy of Laminin alpha2 chain deficiency?

Författare

Summary, in English

Gene therapy holds great promise for treating many genetic diseases, including muscular dystrophies. Mutations in the gene encoding laminin alpha2 chain ? an extracellular protein prominently expressed in the neuromuscular system ? cause a severe neuromuscular disorder: congenital muscular dystrophy type 1A (MDC1A). Currently, there is no treatment for MDC1A. Preclinical studies are the first step in testing genetic approaches for future gene therapy in humans. In the course of my research, I focused on a genetically manipulated mouse model of MDC1A, investigating whether the transgenic introduction of laminin ?1 chain into laminin alpha2 chain deficient tissues would prevent the development of disease symptoms.



The overexpression of laminin alpha1 chain greatly improved overall health and normalized the life span of laminin alpha2 chain deficient animals. Laminin alpha1 chain, which in the adult body is expressed only in a few epithelial tissues, functionally compensated for laminin alpha2 chain loss in muscle, peripheral nervous system and testis, correcting their morphology and restoring their function. Moreover, laminin alpha1 chain proved to be essential for the normal expression levels of laminin receptors dystroglycan and integrin alpha7 in laminin alpha2 chain deficient muscle. I suggest that our preclinical studies with laminin alpha1 chain transgene may serve as a paradigm for gene therapy of congenital muscular dystrophy in patients.

Avdelning/ar

Publiceringsår

2006

Språk

Engelska

Dokumenttyp

Doktorsavhandling

Förlag

Faculty of Medicine, Department of Experimental Medical Science

Ämne

  • Basic Medicine

Nyckelord

  • laminin
  • muscular dystrophy
  • gene therapy
  • Histology
  • cytochemistry
  • histochemistry
  • tissue culture
  • Histologi
  • cytokemi
  • histokemi
  • vävnadskultur
  • Genetics
  • cytogenetics
  • cytogenetik
  • Skeleton
  • muscle system
  • rheumatology locomotion
  • Skelett
  • muskelsystem
  • reumatologi
  • Genetik

Status

Published

Forskningsgrupp

  • Muscle Biology

ISBN/ISSN/Övrigt

  • ISBN: 91-85559-55-5

Försvarsdatum

9 december 2006

Försvarstid

09:00

Försvarsplats

Biomedical Centre, Sölvegatan 19 GK Salen

Opponent

  • Marcus Ruegg (Professor)